Abstract

Kaposi’s sarcoma-associated herpesvirus (KSHV) and Epstein-Barr Virus (EBV) establish life-long infections and are associated with malignancies. Striking geographic variation in incidence and the fact that virus alone is insufficient to cause disease, suggests other co-factors are involved. Here we present epidemiological analysis and genome-wide association study (GWAS) in 4365 individuals from an African population cohort, to assess the influence of host genetic and non-genetic factors on virus antibody responses. EBV/KSHV co-infection (OR = 5.71(1.58–7.12)), HIV positivity (OR = 2.22(1.32–3.73)) and living in a more rural area (OR = 1.38(1.01–1.89)) are strongly associated with immunogenicity. GWAS reveals associations with KSHV antibody response in the HLA-B/C region (p = 6.64 × 10−09). For EBV, associations are identified for VCA (rs71542439, p = 1.15 × 10−12). Human leucocyte antigen (HLA) and trans-ancestry fine-mapping substantiate that distinct variants in HLA-DQA1 (p = 5.24 × 10−44) are driving associations for EBNA-1 in Africa. This study highlights complex interactions between KSHV and EBV, in addition to distinct genetic architectures resulting in important differences in pathogenesis and transmission.

Highlights

  • Narrow-sense heritability (h2) for anti-EBNA-1 IgG, anti-VCA IgG, anti-ORF73 IgG, anti-K8.1 IgG and antiK10.5 IgG traits were estimated using a linear mixed model (LMM) in FaST-LMM with two random effects, one based on genetic effects and the other on environmental effects using spatial location[31] recorded as Global Position System (GPS) coordinates as a proxy for environmental effects

  • To identify distinct SNPs, conditional analysis was performed in GEMMA

  • If any SNP was statistically significant, it was added stepwise onto the mixed model and analysed jointly; this was done until no SNPs with p < 5 × 10−9 11,33 remained

Read more

Summary

Introduction

Narrow-sense heritability (h2) for anti-EBNA-1 IgG, anti-VCA IgG, anti-ORF73 IgG, anti-K8.1 IgG and antiK10.5 IgG traits were estimated using a linear mixed model (LMM) in FaST-LMM with two random effects, one based on genetic effects and the other on environmental effects using spatial location[31] recorded as Global Position System (GPS) coordinates as a proxy for environmental effects. The statistical power to identify genetic variants of genome-wide significance and with different effect sizes given the sample size was estimated using QUANTO software (http://biostats.usc.edu/ software). We conducted analyses for all quantitative antibody traits for KSHV (N = 4365) and EBV (N = 3289 and N = 4365 (including overlapping samples from pilot study) by first applying a multivariable linear regression model adjusting for significant covariates in R.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call